Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com
As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease.
The company routinely posts information that may be important to investors on its website at www.biogen-gulf.com. To learn more, please visit www.biogen-gulf.com and and follow Biogen on social media youtube, facebook, linkedin, and twitter.
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”
More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Sanofi is dedicated to supporting people through their health challenges. We are a global Biopharmaceutical Company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi, Empowering Life.
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy.
AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech.
Since the beginning, our mission hasn’t wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
With a proven track record for providing medicines, vaccines and consumer products, the company has a long-standing innovation history of over 300 years and its presence in the Gulf has been expanding for the last 65 years – providing greater access and innovation to people in the region ever since.
For further information please visit:
Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases, We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.
As a leading provider of high-quality medicines, our strategy is to make healthcare more accessible by delivering more from our strong foundation, building a portfolio that anticipates future health needs and inspiring and enabling our people.
Our brand promise
Better health. Within reach. Every day. By creating high-quality products and making them accessible to those who need them we are helping to shape a healthier world that enriched all of our communities.
Founded more than 40 years ago, our purpose has always been to provide high-quality, affordable medicines to the people who need them. Based on the solid foundation we have built, we will continue to innovate and find practical solutions to transform the lives of the millions of people we serve.
Our vision is of a healthier world that enriches all of our communities. Throughout the past 40+ years, we’ve been guided by the simple belief that when world-class medicine is put within people’s reach, it has the ability to transform their lives and their communities.
Today at Hikma we now have the reach, insight and expertise to transform so many more people’s lives.
And in a fast-changing world, our commitment to our vision is as important as ever – not only for Hikma, but also for the millions of people we serve around the world.
Our four values are the collectively held principles of our people that shape the way we think, work and behave:
Integrity: Acting with honesty and honour without compromising the truth.
Excellence: Holding people accountable to the highest standards of performance.
Respect: Showing consideration for one another, recognising each other’s differences, needs and expectations.
Transparency: Embodying openness, communication and accountability. Operating clearly and openly, making it easy for others to observe performance
Our passion for science and technology is what drives our 58,000 employees in 66 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live.
We are here for people at every step, helping to create, im-prove and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services and digital platform make research simpler, more exact, and help to deliver breakthroughs more quickly. Our solutions accelerate access to health by assuring tests are accurate and the medicine we take can be trusted. We are the company behind the companies, advancing digital living. Our science sits inside technologies that are changing the way we access, store, process, and display information. Our innovations are unlocking the power and potential of data to open new possibilities to transform life on Earth as we know it.
Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we’ve been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
EVER Neuro Pharma is a successful Austrian pharmaceutical specialist focused on the field of neuroscience. Based on our experience and proprietary R&D technology platform we develop innovative therapies for neurological disorders aimed at improving both the patients’ well-being and quality of life.
Among other agents, our product portfolio is strengthened with Dacepton® (apomorphine hydrochloride) for the treatment of disabling motor symptoms in the advanced stage of Parkinson´s disease. We focus on the complete Package of Care including innovative D-mine® Medical Devices for the intermittent and continuous drug delivery.
Cerebrolysin® is a biotechnologically manufactured original neuropeptide solution that stimulates neurotrophic regulation in the central nervous system. It is indicated for the treatment of stroke, traumatic brain injuries and cognitive impairment/dementia.
Tachyben® is used for intravenous treatment of hypertensive emergencies. It is used to control lowering of blood pressure in hypertensive patients during and/or after surgery in cases of severe forms of hypertensive disease.
Recognizing current trends, we keep to our endeavour for further and constant improvement of our patient-oriented services.
Exeltis is a Spanish based speciality company, a result of the natural evolution and sustained growth of the Insud Pharma pharmaceutical business, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a global organization with the capacity to discover, develop, produce and market medicinal products and medical devices that can help to improve the quality of life of millions of people worldwide.
NewBridge Pharmaceuticals, headquartered in Dubai – U.A.E., is a regional specialty
pharmaceutical company focused on in-licensing and commercializing USFDA and/or EMA
approved innovative therapeutics that address unmet medical needs in the Middle East and
NewBridge’s current focus is to bring innovation to enhance the patient’s journey in the field of
oncology, immunology, neuroscience, gastrointestinal and rare diseases.
For more information visit: www.nbpharma.com
if you are an organization or industry who seeks for a platform to promote your brand,
then this conference is for you!
please feel free to contact us to know more about the sponsorship opportunities that awaits you.
For more information, please contact: